Clinical Trials Browser

Phase 2 × Not yet recruiting × Esthesioneuroblastoma, Olfactory × Clear all

NCT07527169 2026-04-14

A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

Phase 2 Not yet recruiting

Esthesioneuroblastoma, Olfactory